SCHEMBL903236

SCHEMBL903236

CC(C)(C)c1ccc2nnc(C(F)(F)F)n2n1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CYP1A2 P05177 5/20 0.50
SCN5A Q14524 3/20 0.49
ALOX15 P16050 1/20 0.49
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
XBP1 P17861 1/20 0.47
HPGD P15428 1/20 0.47
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CHEK1 O14757 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18352336 0.87 ALDH1A1 (0.43) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL13248529 0.83 ALDH1A1 (0.40) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL13248528 0.83 ALDH1A1 (0.40) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL12911394 0.79 ALDH1A1 (0.64) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL13248521 0.77 SMN1; SMN2 (0.49) ALDH1A1HTTTDP1CYP1A2MAPT
SCHEMBL12909169 0.76 CYP1A2 (0.68) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL13248522 0.75 POLB (0.44) ALDH1A1HTTMAPTHPGDKDM4E
SCHEMBL750158 0.75 ALDH1A1 (1.00) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL939060 0.75 ALDH1A1 (0.64) ALDH1A1HTTTDP1CYP1A2SCN5A
SCHEMBL2362190 0.75 ALDH1A1 (0.64) ALDH1A1HTTTDP1CYP1A2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041524-A1 HYDRAZONOPYRAZOLONES AS PROTEIN TYROSINE PHOSPHATASE INHIBITORS MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (MDC) (DE) 2012-04-05 WO disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B ALDH1A1 159/4885HTT 4468/4885TDP1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.